Make wishtv.com your home page

How Charlie Kimball plans for the Indy 500

Have you heard? Indy Car driver, Charlie Kimball is doing a few things differently at this year’s Indy 500 and will be making announcements mid-May – on what is changing. Today on Indy Style, Charlie chats about the new program specifically for the 100th running of the Indianapolis 500, the importance of this year compared to years past and the HUGE number of family members that will be attending the event this year!

Charlie also chats about his live with diabetes. He was diagnosed with type 1 diabetes in 2007, and in addition to sporting the logo on his car, takes Tresiba®, along with a mealtime insulin, as part of his daily diabetes management. As part of the efforts to raise diabetes awareness at the Indianapolis 500, Kimball’s No. 42 Tresiba® Chevrolet will carry the name of 42 leaders in the diabetes community. Included among the names on the car are Dominique Wilkins, Billie Jean King, diabetes organizations such as JDRF, and first all-diabetes professional cycling team, Team Novo Nordisk. Additionally, Novo Nordisk will make a $4,200 donation to the Indiana Chapter of the American Diabetes Association (ADA) on behalf of the Verizon IndyCar Series driver who is leading the race after the 42nd lap of the Indianapolis 500. Novo Nordisk will also make the same $4,200 donation to the Charlotte Chapter of the ADA on behalf of the NSCS driver who leads the Coke 600 after lap 42.

The 2016 race season marks the eighth consecutive year of partnership between Novo Nordisk and Kimball and the sixth year of partnership between Kimball, Novo Nordisk and CGRT. Since his type 1 diabetes diagnosis, Kimball has been a passionate diabetes advocate. He is the face of Novo Nordisk’s award-winning Race with Insulin® campaign, which aims to raise awareness and educate the public about diabetes management.

For the remainder of the 2016 Verizon IndyCar Series campaign, Kimball will run his normal car number, No. 83. Continue to follow Charlie’s journey and his work with Novo Nordisk at RaceWithInsulin.com, learn more about Tresiba® at Tresiba.com, or follow Charlie on Twitter at @RaceWithInsulin.

To learn more, visit www.Racewithinsulin.com or Twitter: @Racewithinsulin.